A phase II study to evaluate the efficacy and safety of fruquintinib combined with envafolimab in patients with advanced or unresectable locally advanced osteosarcoma and soft tissue sarcoma.

Authors: Chenliang Zhou, Guowei Qian, Hongtao Li, Yonggang Wang, Qingyu Chen, Zan Shen, Shuier Zheng

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e23506

Source: Full article

e23506